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Introduction
Peptides and peptidyl molecules are regarded as the
bridge between antibodies and small molecule
drugs due to their ability to target regions
“undruggable” by the latter two therapeutics (i.e.,
protein-protein interactions). For peptide
therapeutics to be viable, they must be able to cross
cellular membranes to reach their targets. Cyclic
cell-penetrating peptides have been proven to enter
cells more efficiently than their linear counterparts,
thus most of the drug development efforts are
focused on this type of peptides. Despite this, the
mechanisms with which cyclic CPPs enter cells
remain elusive, and comprehensive methods to
improve their cell delivery rate are yet to be
developed.
This review compiled information from published
literature on cyclic CPPs to synthesize a
comprehensive review on the classification, modes
of cellular penetration, and methods to improve
cellular entry of cyclic CPPs. The classification
focused on de novo synthetic cyclic CPPs.
Materials and methods
The outline of this review was synthesized by
screening previously published articles on CPPs and
cyclic CPPs. Details of each section were compiled
from relevant peer reviewed articles identified from
Google Scholar and PubMed databases.
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Conclusions
Advancements in de novo peptide synthesis have
made the discovery of cyclic CPPs with high
specificity and affinity an attainable goal. The issue
with peptide therapeutic development is now to
improve the peptide’s cellular penetration.
Depending on the structure and concentration,
peptides vary in their cellular entry rate and
mechanism. Similarly, there are many strategies to
improve the penetration rate of CPPs, including
bicyclization, D-amino acid substitution, and non-
proteogenic amino acid substitution. Understanding
the penetration mechanisms and how to identify
which mechanism is taking place will allow for
application of the appropriate penetration-
enhancement strategies.
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Figure 1. Sections of the review in chronological order.
Figure 2. Cellular entry pathways of CPPs. Passive diffusion is
when CPPs crosses the plasma membrane without disrupting the
lipid bilayer and using ATP. Direct translocation involves
disruption of the plasma membrane and temperatures above 4oC.
Endocytosis involves CPPs being internalized by the plasma
membrane forming endosomes, which the peptides need to lyse




Temperatures below 4oC, ATP depletion, 
pyrene butyrate (promoter)
Macropinocytosis Cytochalasin D, amiloride 




Table 1. Inhibitors and promoters used to determine cellular 
entry mechanisms.   
A B
C D
Figure 3. Types of de novo peptide synthesis. A) Synthesis from a
phage library. B) Synthesis from an mRNA library. C) Synthesis by
split-intein circular ligation of peptides and proteins (SICLOPPS).





Example: cyclosporin A Example: Romidepsin











Table 2. Cyclization strategies of monocyclic and bicyclic 
peptides.
Figure 4. Cyclosporin A, an example of a natural cyclic CPP
that can passively diffuse into the cell. The peptide has N-
methylated amino acids (in blue), non-canonical and lipophilic
side chains (in red), and a D-amino acid (in green). Source: (6)
